Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University College, London
Takeda
Merck Sharp & Dohme LLC
Centre Hospitalier Universitaire Dijon
Fondazione Italiana Linfomi - ETS
Memorial Sloan Kettering Cancer Center
Fondazione Italiana Linfomi - ETS
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Shanghai Junshi Bioscience Co., Ltd.
Angiocrine Bioscience
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
University College, London
Bristol-Myers Squibb
University College, London
Case Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Children's Oncology Group
Northwell Health
Medical College of Wisconsin
Fondazione Michelangelo
Seagen Inc.
Takeda
Children's Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
University of Cologne
University of Cologne
The Netherlands Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Mesoblast, Ltd.
Canadian Cancer Trials Group
University of Cologne
Canadian Cancer Trials Group
Martin-Luther-Universität Halle-Wittenberg
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Children's Oncology Group
Vanderbilt-Ingram Cancer Center
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group